GlassScriptPhysician profile
Carl Barosso
NPI 1710186036
$1,582.52
in general payments reported to CMS, 2019-2025
16 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $79.13 · 2022: $153 · 2023: $30.37 · 2024: $658 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $628.14 | 2019-2025 | Eluvia, Enroute Transcarotid Stent, General - Vascular Intervention |
| Medtronic, INC. | $345.03 | 2022-2024 | Endurant Iis |
| Medtronic Vascular, INC. | $139.00 | 2019 | |
| Ethicon US, LLC | $106.60 | 2024 | Ethicon, Vistaseal, Prolene |
| Silk Road Medical, INC. | $91.71 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Livanova USA, INC. | $40.77 | 2019-2020 | |
| Getinge USA Sales, LLC | $36.86 | 2019-2020 | |
| Edwards Lifesciences Corporation | $32.21 | 2019 | |
| Zimmer Biomet Holdings, INC. | $28.44 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $24.62 | 2025 | |
| Cook Medical LLC | $22.38 | 2019 | |
| Chiesi USA, INC. | $19.80 | 2020 | |
| Terumo Medical Corporation | $19.10 | 2019 | |
| Bard Access Systems, INC. | $17.92 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.52 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $14.42 | 2025 | Vascband |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Barosso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.